<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: <z:hpo ids='HP_0011010'>Chronic</z:hpo> <z:hpo ids='HP_0001635'>heart failure</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CHF</z:e>) is a major and growing public health problem resulting from the cardiac damage caused by a variety of disease processes </plain></SENT>
<SENT sid="1" pm="."><plain><z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CHF</z:e> has many comorbid conditions such as <z:hpo ids='HP_0000822'>hypertension</z:hpo>, <z:hpo ids='HP_0001677'>coronary artery disease</z:hpo>, peripheral artery disease and <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:e sem="disease" ids="C0022658" disease_type="Disease or Syndrome" abbrv="">kidney disease</z:e> (CKD) </plain></SENT>
<SENT sid="2" pm="."><plain>Some of the <z:hpo ids='HP_0011010'>chronic</z:hpo> conditions may have an effect on cardiac mortality in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CHF</z:e> patients </plain></SENT>
<SENT sid="3" pm="."><plain>We have investigated the effect of <z:hpo ids='HP_0000082'>renal dysfunction</z:hpo> on cardiovascular mortality in patients with ischemic <z:hpo ids='HP_0001644'>dilated cardiomyopathy</z:hpo> (<z:chebi fb="20" ids="15767">DCM</z:chebi>) and nonischemic <z:chebi fb="20" ids="15767">DCM</z:chebi> </plain></SENT>
<SENT sid="4" pm="."><plain>METHODS: Six hundred and thirty-seven patients with <z:chebi fb="20" ids="15767">DCM</z:chebi> were evaluated between January 2003 and January 2011 </plain></SENT>
<SENT sid="5" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> individuals in the study population were admitted to the cardiology clinic because of decompensated <z:hpo ids='HP_0001635'>heart failure</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>In this prospective observational study, a total of 637 patients [409 men, 228 women, 18-94 years old, mean age 63 ± 13 years; New York Heart Association (NYHA) functional class II-IV] with diagnoses of ischemic (402) and nonischemic (235) <z:chebi fb="20" ids="15767">DCM</z:chebi> were enrolled in the study </plain></SENT>
<SENT sid="7" pm="."><plain>Baseline glomerular filtration rate was calculated using the Cockcroft-Gault equation </plain></SENT>
<SENT sid="8" pm="."><plain>RESULTS: By the end of the study, 228 patients had died due to cardiovascular reasons </plain></SENT>
<SENT sid="9" pm="."><plain>Both <z:chebi fb="20" ids="15767">DCM</z:chebi> types had similar cardiovascular mortality [151 patients with ischemic <z:chebi fb="20" ids="15767">DCM</z:chebi> (37%) vs. 77 patients with nonischemic <z:chebi fb="20" ids="15767">DCM</z:chebi> (32%); P = NS] </plain></SENT>
<SENT sid="10" pm="."><plain><z:hpo ids='HP_0000082'>Renal dysfunction</z:hpo> had an effect on cardiovascular mortality in patients with ischemic and nonischemic <z:chebi fb="20" ids="15767">DCM</z:chebi> (respectively, glomerular filtration rate 54 ± 24, 56 ± 24; P &lt; 0.001) </plain></SENT>
<SENT sid="11" pm="."><plain>CONCLUSION: We have demonstrated that renal function is a prognostic risk marker in patients with ischemic and nonischemic <z:chebi fb="20" ids="15767">DCM</z:chebi> </plain></SENT>
</text></document>